Intratarsal injection of kenacort in the treatment of severe cases of VKC

• Published in: Acta ophthalmologica (Oxford, England) England), 2015-10, Vol.93 (S255), p.n/a
• Main Author: Lazreg, S.
• Format: Article
• Language: English
• ISSN: 1755-375X; 1755-3768
• DOI: 10.1111/j.1755-3768.2015.1347

Purpose To treat refractory cases of Vkc with intratarsal injections of trialcinolone. Methods We treated Severe cases of Vkc that have already experienced different anti allergic treatments and topical steroids with frequent relapses and dependancies to steroids with intratarsal injection of 40 mg of dexametasone, the follow up visits were performed at D0, D3, D7 and D30 (slit lamp examination, corneal staining, ocular pressure). Results 87 severe cases of Vkc 63 males, mean age 10.4±3.5 years, 90% bilateral, and 100% of corneal involvement. 70% mixed forms and 15% of tarsal forms, the mean follow up was 20 ± 7 months. at D3 we had a decrease of all ocular signs (photophobia, redness and pruritis) at D7 decrease of corneal staining and trantas nods, and at d30, total remission of the Vkc, the mean duration of the efficacy of the treatment was 10.4 ± 2.6 months, no adverse event was observed. Conclusions Intratarsal injection of steroids is very effective in severe and resistant cases of Vkc, especially in our countries where this disease is very severe, frequent and when topical cyclosporine is not available.